Dwarfism: Clinical Trials

2 trials for Dwarfism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 enrolling by invitation. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Enrolling by invitation 2
Phase 32Enrolling by invitation 2

Follow Dwarfism: new trials by email Literature Review of Dwarfism trials Research Report on Dwarfism

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Interventional Study of Infigratinib in Children With Hypochondroplasia
infigratinib 0.128 mg/kg/day, infigratinib 0.25 mg/kg/day - Hypochondroplasia
Phase 2 / Phase 3Enrolling by invitationQED Therapeutics, a BridgeBio company242025-04-222026-07-16
A Clinical Trial to Investigate Long-term Safety, Tolerability, and Efficacy of Weekly Subcutaneous Doses With TransCon CNP in Children and Adolescents With Achondroplasia
TransCon CNP - Achondroplasia
Phase 2 / Phase 3Enrolling by invitationAscendis Pharma Growth Disorders A/S1402023-06-212026-08-17

Narrower conditions

Achondroplasia (1)  ·  Bone Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Hypochondroplasia (1)  ·  Mucopolysaccharidosis IV (1)  ·  Musculoskeletal Diseases (1)  ·  Osteochondrodysplasias (1)

Broader conditions

Bone Diseases, Developmental (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Endocrine System Diseases (2)  ·  Bone Diseases (1)  ·  Carbohydrate Metabolism, Inborn Errors (1)  ·  Connective Tissue Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Lysosomal Storage Diseases (1)  ·  Metabolic Diseases (1)  ·  Metabolism, Inborn Errors (1)  ·  Mucinoses (1)  ·  Mucopolysaccharidoses (1)  ·  Musculoskeletal Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Osteochondrodysplasias (1)

Interventions

infigratinib (1)

Sponsors

Ascendis Pharma Growth Disorders A/S (1)  ·  QED Therapeutics, a BridgeBio company (1)

Countries

Australia (2)  ·  Canada (2)  ·  France (2)  ·  Portugal (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Austria (1)  ·  Denmark (1)  ·  Germany (1)  ·  Ireland (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Singapore (1)  ·  Sweden (1)